Coste de la psoriasis y artritis psoriásica en cinco países de Europa: una revisión sistemática
Authors:
- 1 September 2016
- journal article
- research article
- Published by Elsevier in Actas Dermo-Sifiliograficas
- Vol. 107 (7) , 577-590
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Cost-of-Illness in Psoriasis: Comparing Inpatient and Outpatient TherapyPLOS ONE, 2013
- Treatment of Psoriasis and Psoriatic ArthritisBioDrugs, 2013
- A retrospective cohort study of the impact of biologic therapy initiation on medical resource use and costs in patients with moderate to severe psoriasisBritish Journal of Dermatology, 2010
- Estimation of health care costs as a function of disease severity in people with psoriatic arthritis in the UKRheumatology, 2010
- The economic impact of high-need psoriasis in daily clinical practice before and after the introduction of biologicsBritish Journal of Dermatology, 2010
- Eficiencia de los agentes biológicos en el tratamiento de la psoriasis moderada-graveActas Dermo-Sifiliograficas, 2009
- The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapyRheumatology, 2008
- Costs and quality of life in patients with moderate to severe plaque‐type psoriasis in Germany: A multi‐center studyJDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2007
- A prospective evaluation of the cost of psoriasis in Spain (EPIDERMA project: Phase II)Journal of the European Academy of Dermatology and Venereology, 2006
- The friction cost method for measuring indirect costs of diseaseJournal of Health Economics, 1995